Toril Holien

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Epithelial Mesenchymal Transition

Transforming Growth Factor

Cell Cycle Arrest

Top Venues

Chemical science

This page only lists publications with an associated author ORCID identifier.

Publications

Eidi Christensen, Olav Andreas Foss, Toril Holien, Petras Juzenas, Qian Peng
Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Cutaneous T-Cell Lymphoma: A First-in-Human Phase I/II Study. Pharmaceutics 16 (6) (2024)
Eidi Christensen, Olav Andreas Foss, Toril Holien, Petras Juzenas, Qian Peng
Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Cutaneous T-Cell Lymphoma: A First-in-Human Phase I/II Study. Pharmaceutics 16 (6) (2024)
Katrine Melvold, Mariaserena Giliberto, Linda Karlsen, Pilar Ayuda-Durán, Robert Hanes, Toril Holien, Jorrit Enserink, Jennifer R Brown, Geir E Tjønnfjord, Kjetil Taskén, Sigrid S Skånland
Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B cell malignancies. Molecular oncology (2021)
Jürgen M Kolos, Sebastian J Pomplun, Sascha Jung, Benedikt Rieß, Patrick L Purder, Andreas M Voll, Stephanie Merz, Monika Gnatzy, Thomas M Geiger, Ingrid Quist-Løkken, Jerome Jatzlau, Petra Knaus, Toril Holien, Andreas Bracher, Christian Meyners, Paul Czodrowski, Vera Krewald, Felix Hausch
Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3.1] aza-amides. Chemical science 12 (44) (2021)
Aleksandr Ianevski, Evgeny Kulesskiy, Klara Krpina, Guofeng Lou, Yahyah Aman, Andrii Bugai, Koit Aasumets, Yevhen Akimov, Daria Bulanova, Kiira Gildemann, Albert F Arutyunyan, Olga Yu Susova, Alexei L Zhuze, Ping Ji, Wei Wang, Toril Holien, Marit Bugge, Eva Zusinaite, Valentyn Oksenych, Hilde Lysvand, Joachim M Gerhold, Magnar Bjørås, Pål Johannsen, Anders Waage, Caroline A Heckman, Evandro Fei Fang, Denis E Kainov
Chemical, Physical and Biological Triggers of Evolutionary Conserved Bcl-xL-Mediated Apoptosis. Cancers 12 (6) (2020)
Oddrun Elise Olsen, Hanne Hella, Samah Elsaadi, Carsten Jacobi, Erik Martinez-Hackert, Toril Holien
Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors. Biomolecules 10 (4) (2020)
Marita Westhrin, Toril Holien, Muhammad Zahoor, Siv Helen Moen, Glenn Buene, Berit Størdal, Hanne Hella, Huipin Yuan, Joost D de Bruijn, Anton Martens, Richard Wj Groen, Fatima Bosch, Ulf Smith, Anne-Marit Sponaas, Anders Sundan, Therese Standal
Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone. JBMR plus 4 (1) (2019)
Ulrike Neckmann, Camilla Wolowczyk, Martina Hall, Eivind Almaas, Jiang Ren, Sen Zhao, Bjarne Johannessen, Rolf I Skotheim, Geir Bjørkøy, Peter Ten Dijke, Toril Holien
GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients. Cell communication and signaling : CCS 17 (1) (2019)
Oddrun Elise Olsen, Meenu Sankar, Samah Elsaadi, Hanne Hella, Glenn Buene, Sagar Ramesh Darvekar, Kristine Misund, Takenobu Katagiri, Petra Knaus, Toril Holien
BMPR2 inhibits activin and BMP signaling via wild-type ALK2. Journal of cell science 131 (11) (2018)
Toril Holien, Odrun Arna Gederaas, Sagar Ramesh Darvekar, Eidi Christensen, Qian Peng
Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo. Lasers in surgery and medicine 50 (5) (2018)
Oddrun Elise Olsen, Anette Skjærvik, Berit Fladvad Størdal, Anders Sundan, Toril Holien
TGF-β contamination of purified recombinant GDF15. PloS one 12 (11) (2017)